Company profile BCLI
There is not enough data for Brainstorm Cell Therapeutics - biotechnology to provide analysis
There is not enough data for Brainstorm Cell Therapeutics - biotechnology to provide correlation calculation
There is not enough data for Brainstorm Cell Therapeutics - biotechnology to provide analysis
There is not enough data for autologous cellular therapies to provide analysis
There is not enough data for autologous cellular therapies to provide correlation calculation
There is not enough data for autologous cellular therapies to provide analysis
After 39 days of this quarter the interest is at 228.0. Based on that we can calculate that during remaining 52 days it will total up to 532.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 205 | 215 4.9% QoQ | 240 11.6% QoQ | 273 13.8% QoQ |
| 2020 | 262 27.8% YoY -4.0% QoQ | 246 14.4% YoY -6.1% QoQ | 200 -16.7% YoY -18.7% QoQ | 255 -6.6% YoY 27.5% QoQ |
| 2021 | 202 -22.9% YoY -20.8% QoQ | 310 26.0% YoY 53.5% QoQ | 211 5.5% YoY -31.9% QoQ | 276 8.2% YoY 30.8% QoQ |
| 2022 | 370 83.2% YoY 34.1% QoQ | 305 -1.6% YoY -17.6% QoQ | 279 32.2% YoY -8.5% QoQ | 314 13.8% YoY 12.5% QoQ |
| 2023 | 469 26.8% YoY 49.4% QoQ | 394 29.2% YoY -16.0% QoQ | 333 19.4% YoY -15.5% QoQ | 433 37.9% YoY 30.0% QoQ |
| 2024 | 228 -51.4% YoY -47.3% QoQ | - | - | - |
The average 5 years interest of neurodegenerative diseases was 23.07 per week. The last year interest of neurodegenerative diseases compared to the last 5 years has changed by 36.8%. The interest for neurodegenerative diseases is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 56.86%.
There is not enough data for NurOwn cell therapy to provide analysis
There is not enough data for NurOwn cell therapy to provide correlation calculation
There is not enough data for NurOwn cell therapy to provide analysis
After 39 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 52 days it will total up to 58.0. amyotrophic lateral sclerosis treatment expected interest is significantly lower compared to previous quarter (-70.1%) and same quarter last year (-66.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 66 | 100 51.5% QoQ | 40 -60.0% QoQ | 177 342.5% QoQ |
| 2020 | 161 143.9% YoY -9.0% QoQ | 91 -9.0% YoY -43.5% QoQ | 55 37.5% YoY -39.6% QoQ | 37 -79.1% YoY -32.7% QoQ |
| 2021 | 115 -28.6% YoY 210.8% QoQ | 43 -52.7% YoY -62.6% QoQ | 120 118.2% YoY 179.1% QoQ | 197 432.4% YoY 64.2% QoQ |
| 2022 | 194 68.7% YoY -1.5% QoQ | 79 83.7% YoY -59.3% QoQ | 60 -50.0% YoY -24.1% QoQ | 128 -35.0% YoY 113.3% QoQ |
| 2023 | 174 -10.3% YoY 35.9% QoQ | 220 178.5% YoY 26.4% QoQ | 128 113.3% YoY -41.8% QoQ | 194 51.6% YoY 51.6% QoQ |
| 2024 | 25 -85.6% YoY -87.1% QoQ | - | - | - |
The average 5 years interest of amyotrophic lateral sclerosis treatment was 9.21 per week. The last year interest of amyotrophic lateral sclerosis treatment compared to the last 5 years has changed by 47.99%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 58.49%.
There is not enough data for progressive multiple sclerosis treatment to provide analysis
There is not enough data for progressive multiple sclerosis treatment to provide correlation calculation
There is not enough data for progressive multiple sclerosis treatment to provide analysis
After 34 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 58 days it will total up to 430.0. Alzheimer's disease treatment expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 177 |
| 2019 | 176 -0.6% QoQ | 151 -14.2% QoQ | 237 57.0% QoQ | 286 61.6% YoY 20.7% QoQ |
| 2020 | 277 57.4% YoY -3.1% QoQ | 184 21.9% YoY -33.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 159 inf% YoY inf% QoQ |
The average 5 years interest of Alzheimer's disease treatment was 6.31 per week. The last year interest of Alzheimer's disease treatment compared to the last 5 years has changed by -51.51%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -80.88%.
After 38 days of this quarter the interest is at 94.0. Based on that we can calculate that during remaining 53 days it will total up to 225.0. neurotrophic factors expected interest is significantly higher compared to previous quarter (+112.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 124 | 162 30.6% QoQ | 64 -60.5% QoQ | 260 306.2% QoQ |
| 2020 | 228 83.9% YoY -12.3% QoQ | 296 82.7% YoY 29.8% QoQ | 91 42.2% YoY -69.3% QoQ | 327 25.8% YoY 259.3% QoQ |
| 2021 | 280 22.8% YoY -14.4% QoQ | 226 -23.6% YoY -19.3% QoQ | 102 12.1% YoY -54.9% QoQ | 124 -62.1% YoY 21.6% QoQ |
| 2022 | 204 -27.1% YoY 64.5% QoQ | 173 -23.5% YoY -15.2% QoQ | 142 39.2% YoY -17.9% QoQ | 145 16.9% YoY 2.1% QoQ |
| 2023 | 275 34.8% YoY 89.7% QoQ | 163 -5.8% YoY -40.7% QoQ | 199 40.1% YoY 22.1% QoQ | 106 -26.9% YoY -46.7% QoQ |
| 2024 | 94 -65.8% YoY -11.3% QoQ | - | - | - |
The average 5 years interest of neurotrophic factors was 14.56 per week. The last year interest of neurotrophic factors compared to the last 5 years has changed by -0.41%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -0.14%.
There is not enough data for neuroinflammatory disease treatment to provide analysis
There is not enough data for neuroinflammatory disease treatment to provide correlation calculation
There is not enough data for neuroinflammatory disease treatment to provide analysis
After 39 days of this quarter the interest is at 75.0. Based on that we can calculate that during remaining 52 days it will total up to 175.0. neurodegenerative disease treatment expected interest is significantly higher compared to previous quarter (+63.6%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 29 | 55 89.7% QoQ | 109 98.2% QoQ | 116 6.4% QoQ |
| 2020 | 84 189.7% YoY -27.6% QoQ | 110 100.0% YoY 31.0% QoQ | 161 47.7% YoY 46.4% QoQ | 61 -47.4% YoY -62.1% QoQ |
| 2021 | 77 -8.3% YoY 26.2% QoQ | 223 102.7% YoY 189.6% QoQ | 131 -18.6% YoY -41.3% QoQ | 139 127.9% YoY 6.1% QoQ |
| 2022 | 100 29.9% YoY -28.1% QoQ | 244 9.4% YoY 144.0% QoQ | 242 84.7% YoY -0.8% QoQ | 126 -9.4% YoY -47.9% QoQ |
| 2023 | 158 58.0% YoY 25.4% QoQ | 149 -38.9% YoY -5.7% QoQ | 171 -29.3% YoY 14.8% QoQ | 107 -15.1% YoY -37.4% QoQ |
| 2024 | 75 -52.5% YoY -29.9% QoQ | - | - | - |
The average 5 years interest of neurodegenerative disease treatment was 10.22 per week. The last year interest of neurodegenerative disease treatment compared to the last 5 years has changed by 4.79%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 68.66%.
There is not enough data for mesenchymal stem cells... to provide analysis
There is not enough data for mesenchymal stem cells... to provide correlation calculation
There is not enough data for mesenchymal stem cells... to provide analysis